NextGen Healthcare (NASDAQ:NXGN – Get Rating) had its price objective decreased by Guggenheim from $26.00 to $22.00 in a research report released on Tuesday morning, The Fly reports.
NXGN has been the subject of several other research reports. StockNews.com assumed coverage on shares of NextGen Healthcare in a research note on Thursday, May 18th. They issued a buy rating for the company. TheStreet downgraded shares of NextGen Healthcare from a b- rating to a c rating in a research note on Tuesday, May 16th. Piper Sandler decreased their price target on shares of NextGen Healthcare from $20.00 to $17.00 in a research note on Thursday, May 18th. Stephens began coverage on shares of NextGen Healthcare in a research note on Tuesday, April 11th. They issued an overweight rating and a $24.00 price target for the company. Finally, Truist Financial decreased their price target on shares of NextGen Healthcare from $22.00 to $18.00 in a research note on Monday. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of Moderate Buy and an average price target of $21.20.
NextGen Healthcare Trading Down 1.2 %
NASDAQ NXGN opened at $15.45 on Tuesday. The firm has a 50 day simple moving average of $16.98 and a 200-day simple moving average of $18.15. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.53 and a current ratio of 2.03. NextGen Healthcare has a one year low of $15.23 and a one year high of $21.99. The firm has a market cap of $1.02 billion, a price-to-earnings ratio of -386.25 and a beta of 1.04.
Institutional Trading of NextGen Healthcare
About NextGen Healthcare
NextGen Healthcare, Inc provides software and services that empower ambulatory healthcare practices to manage the risk and complexity of delivering care in the rapidly evolving U.S. healthcare system. Its portfolio includes tightly integrated solutions that deliver on ambulatory healthcare imperatives including population health, care management, patient outreach, telemedicine, and nationwide clinical information exchange.
- Get a free copy of the StockNews.com research report on NextGen Healthcare (NXGN)
- Ralph Lauren’s Styled Dividend Is Still In Season
- Dollar Tree Falls As Theft Cuts Into Bottom Line
- Best Buy’s Comeback Is Still At Play, Earnings Call For Patience
- e.l.f. Beauty Has Giant Quarter, Shares Hit New High
- If You Can Only Pick One Stock For The Rest Of 2023, Pick Nvidia
Receive News & Ratings for NextGen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextGen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.